Close

We are happy to announce that we're celebrating 30 years! →

Updated:

New Study Links Proton Pump Inhibitor Medications to Onset of Dementia

A new study released last month concluded that the class of medications referred to as proton pump inhibitors (PPIs) can lead to cognitive decline disorders like dementia. The study involved patients who took PPIs like Prilosec, Nexium, and Prevacid between 2004 and 2011. The full range of pharmaceuticals covered in the study includes raberprazole, esomeprazole, pantoprazole, omeprazole, and lansoprazole.

Roughly 73,600 patients were involved in the study. The patients were over the age of 75 years and did not show signs or a history of dementia at the time the study commenced. At the conclusion of the study, the researchers determined that patients who regularly took PPI medications “had a significantly increased risk of incident dementia compared with patients not receiving PPI medication.”

Until recently, lawsuits filed against AstraZeneca, the maker of Prilosec, Nexium, and Prevacid, have involved allegations that the patients who took the prescription drugs suffered from kidney diseases and heart attacks. This new research provides another potential basis for obtaining recovery from AstraZeneca. If you or a loved one took one of the prescription drugs covered in the study and developed dementia, you may be entitled to compensation.

A plaintiff seeking to hold a drug manufacturer liable can assert a variety of causes of action, including negligence, gross negligence, breach of warranty, and strict product liability. Each of these claims has different elements and standards that the plaintiff must address. In a negligence action against a drug manufacturer, for example, the plaintiff must show that the defendant failed to use reasonable care in developing, manufacturing, and selling the drug.

Alternatively, a product liability claim does not require the plaintiff to show that the defendant did not act with the appropriate level of care. Instead, the plaintiff must prove that the drug was designed in an unreasonably dangerous manner, suffered from a defect during manufacturing, or lacked appropriate warnings and instructions regarding its safe use.

Ensuring that you collect the right evidence to support each of your claims and assert all of the causes of action that apply to your case is a critical aspect of obtaining a successful settlement or a judgment. Moreover, each state imposes time limits on when a plaintiff can bring a personal injury claim against a drug manufacturer. It is crucial to ensure that you file your case within the statute of limitations. Finally, states have also developed different approaches to a variety of issues like expert witness testimony in pharmaceutical cases and whether a spouse, child, or surviving relative can bring a loss of consortium claim against the manufacturer to pursue compensation.

At Moll Law Group, Nexium lawyer Ken Moll understands how devastating injuries stemming from a can be for the victim and his or her family. We have assisted many victims throughout the United States, including in Texas, Illinois, California, and New York. Our dedicated and knowledgeable team of professionals offers free consultations to assist victims with determining the legal options that may be available to them. Call us now at 312-462-1700 or contact us online to set up your appointment.

Related Posts:

West Virginia Judge Dismisses 149 Mesh Lawsuits After C.R. Bard Enters Into Settlement Agreement

FDA Warns About Danger to Humans From Salmonella Contaminated Dog Food

Intuitive Surgical Settles Da Vinci Robot Case on Third Day of Jury Deliberations